If we get FDA approval a range of potential positive benefits...

If we get FDA approval a range of potential positive benefits flow.

Imminent significant cashflow
Increased potential to close ROW
Increased potential value for ROW
Potential ability to fast track 2591 in the 4 current indications
Increased potential for 2591 licensing deal
Potential to implement additional clinical trials for alternative indications in 2591
Imminent inclusion in asx200
Potential inclusion in asx100 (additional significant investors)

That’s a lot of potential value and increased buying pressure to overcome should anyone be trying to keep the shareprice below $20 a few months after approval.